Larvol Delta - Compass-Pathways-Announces-Completion-of-Recruitment-for-the-Phase-3-COMP005-Trial-of-COMP360-Psilocybin-for-TreatmentResistant-Depression

psilocybin (COMP360) - Compass Pathways

https://www.businesswire.com/news/home/20250326830443/en/Compass-Pathways-Announces-Completion-of-Recruitment-for-the-Phase-3-COMP005-Trial-of-COMP360-Psilocybin-for-Treatment-Resistant-Depression

Mar 26, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next